Stroke Prevention With Oral Anticoagulation Therapy in Patients With Atrial Fibrillation
Why the study?
Do oral anticoagulants reduce stroke and systemic embolism safely in elderly patients with atrial fibrillation?
Population
Elderly patients with atrial fibrillation
Comparison
Oral anticoagulants vs Control treatments and younger patients
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Supports OAC use in elderly AF; leaves open optimal agent selection given dabigatran bleeding signal.
Structured PICO
Do oral anticoagulants reduce stroke and systemic embolism safely in elderly patients with atrial fibrillation?
P
Population
Elderly patients with atrial fibrillation
I
Intervention
Oral anticoagulants (vitamin K antagonists and newer oral anticoagulants including apixaban, rivaroxaban, and dabigatran)
C
Comparator
Control treatments and younger patients
O
Outcome
Efficacy (stroke/systemic embolism) and safety (bleeding events)
Oral anticoagulation therapy maintains a positive benefit-risk balance for stroke prevention in elderly patients with atrial fibrillation, supporting its use despite bleeding concerns.
Cite This Study
Lip et al. (2013) studied this question.